YTHDF2 and neoplasm: YTHDF2 knockdown promotes tumor growth and reduces the sensitivity of anti-PD-1 therapy by enhancing the mRNAs stability of the intrinsic genes PD-1 (PDCD1), CXCR4, and SOX10 in an m6A-dependent fashion (284).